# US 2024/0002865 A1 · Methods for Making and Using Genomically Recoded Cells

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0002865 A1
- Document ID: US20240002865A1
- Status: Published application
- Kind: A1
- Application number: 18/255,160
- Filed: 2021-12-07
- Published: 2024-01-04
- Earliest claimed: 2020-12-07
- Assignees: President and Fellows of Harvard College
- Applicants: President and Fellows of Harvard College
- Inventors: George M. Church; Akos Nyerges
- Web page: https://patentgrep.com/patent/US20240002865A1

## CPC

- C12N 15/70: Vectors or expression systems specially adapted for E. coli
- C07K 14/245: Escherichia (G)
- C07K 14/28: from Vibrionaceae (F)
- C07K 14/72: for hormones {(for neuromediators C07K14/70571)}
- C12N 9/22: Ribonucleases {[RNase]; Deoxyribonucleases [DNase]}
- C12N 9/226: {Class 2 CAS enzyme complex, e.g. single CAS protein}
- C12N 15/62: DNA sequences coding for fusion proteins
- C12N 15/63: Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N 15/67: General methods for enhancing the expression
- C12P 21/02: having a known sequence of two or more amino acids, e.g. glutathione
- C07K 14/005: from viruses
- C12N 2770/16022: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C12R 2001/19: Escherichia coli
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12R: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS

## Abstract

Methods making and using genomically recoded cells or organisms are provided including genomically recoded cells or organisms that lack the ability to translate a foreign nucleic acid sequence into a polypeptide that may be toxic to the genomically recoded cell or organism.

## Claims

### Claim 1

A method for altering a cell, wherein the cell lacks expression of one or more tRNA cognate to one or more canonical codons or lacks expression of one or more release factors or otherwise lacks (1) one or more native genes operative to encode one or more tRNA cognate to one or more canonical codons thereby rendering the one or more canonical codons unassigned in the cell or (2) one or more native genes operative to encode one or more release factors comprising
introducing into the cell a foreign nucleic acid sequence of canonical codons encoding a polypeptide, wherein lack of the cell to produce (1) the one or more tRNA cognate to the one or more canonical codons or (2) the one or more release factors prevents expression of the foreign nucleic acid sequence into the polypeptide.

### Claim 2 (depends on 1)

The method of claim 1 wherein the cell is a eukaryotic cell.

### Claim 3 (depends on 1)

The method of claim 1 wherein the cell is a microbial cell.

### Claim 4 (depends on 1)

The method of claim 1 wherein the cell is a bacterial cell.

### Claim 5 (depends on 1)

The method of claim 1 wherein the cell is a yeast cell, a plant cell or a mammalian cell.

### Claim 6 (depends on 1)

The method of claim 1 wherein the cell is a human cell.

### Claim 7 (depends on 1)

The method of claim 1 wherein the polypeptide is a protein.

### Claim 8 (depends on 1)

The method of claim 1 wherein the polypeptide is toxic to the cell.

### Claim 9 (depends on 1)

The method of claim 1 wherein the polypeptide is toxic to the cell, wherein toxicity is determined by a reduction in cell growth rate by at least 1%, 10%, 50%, or 90% compared to growth rate of a corresponding wild type cell.

### Claim 10 (depends on 1)

The method of claim 1 wherein the polypeptide is a protein that is toxic to the cell.

### Claim 11 (depends on 1)

The method of claim 1 wherein the polypeptide is a protein that is toxic to the cell and wherein lack of the cell to produce (1) the one or more tRNA cognate to the one or more canonical codons or (2) the one or more release factors prevents expression of the foreign nucleic acid sequence into the polypeptide, thereby reducing toxicity to the cell of the polypeptide compared to a non-recoded cell of the same strain.

### Claim 12 (depends on 1)

The method of claim 1 wherein the cell is grown to produce a population of cells including the foreign nucleic acid sequence.

### Claim 13 (depends on 1)

The method of claim 1 wherein one or more tRNA cognate to the one or more unassigned codons are provided within the cell, and wherein the cell expresses the foreign nucleic acid sequence into the polypeptide.

### Claim 14

A method for altering a cell comprising providing a cell with a foreign nucleic acid sequence of canonical codons encoding a polypeptide,
wherein one or more canonical codon sequences within the foreign nucleic acid sequence are altered to produce one or more unassigned codons within the cell,
wherein presence of the unassigned codon reduces or prevents expression of the foreign nucleic acid sequence into the polypeptide,
wherein the unassigned codon is optionally located upstream of the nucleic acid sequence encoding the protein,
wherein the unassigned codon is optionally located in a promoter cognate to the foreign nucleic acid sequence, or
wherein the unassigned codon is optionally located within the open reading frame of the foreign nucleic acid sequence.

### Claim at position 15

-26. (canceled)

### Claim 27

A method for expressing a foreign nucleic acid sequence to produce a polypeptide in a cell, wherein the cell lacks expression of one or more tRNA cognate to one or more canonical codons or lacks expression of one or more release factors or otherwise lacks (1) one or more native genes operative to encode one or more tRNA cognate to one or more canonical codons within the foreign nucleic acid sequence or (2) one or more native genes operative to encode one or more release factors comprising
providing the cell with the foreign nucleic acid sequence,
optionally providing the cell with an expression plasmid or vector that is expressed (1) to provide the one or more tRNA cognate to the one or more canonical codons within the foreign nucleic acid sequence or (2) the one or more release factors, wherein the cell translates the foreign nucleic acid sequence to produce the polypeptide, or
optionally, wherein the cell is genetically modified to encode one or more tRNA cognate to one or more canonical codons within the foreign nucleic acid sequence under the influence of an inducible promoter and inducing the inducible promoter to begin translation of the foreign nucleic acid sequence to produce the polypeptide.

### Claim at position 17

-45. (canceled)

### Claim 46

An altered cell lacking expression of one or more tRNA cognate to one or more canonical codons or lacking expression of one or more release factors or otherwise lacking (1) one or more native genes operative to encode one or more tRNA cognate to one or more canonical codons or (2) one or more native genes operative to encode one or more release factors and comprising a foreign nucleic acid sequence of canonical codons encoding a polypeptide.

### Claim at position 19

-56. (canceled)

### Claim 57

An altered cell comprising
a foreign nucleic acid sequence of canonical codons encoding a polypeptide,
wherein the foreign nucleic acid sequence is recoded to include one or more unassigned codons replacing one or more target canonical codons,
wherein the unassigned codon is optionally located upstream of the foreign nucleic acid sequence encoding the protein,
wherein the unassigned codon is optionally located in a promoter cognate to the foreign nucleic acid sequence, or
wherein the unassigned codon is optionally located within the open reading frame of the foreign nucleic acid sequence.

### Claim at position 21

58-67. (canceled)

### Claim 68

An altered cell lacking expression of one or more tRNA cognate to one or more canonical codons or lacking expression of one or more release factors or otherwise lacking (1) one or more native genes operative to encode one or more tRNA cognate to one or more canonical codons within a foreign nucleic acid sequence encoding a polypeptide or (2) one or more native genes operative to encode one or more release factors comprising
the foreign nucleic acid sequence,
an expression plasmid or vector encoding the one or more tRNA cognate to the one or more canonical codons within the foreign nucleic acid sequence or (2) the one or more release factors.

### Claim at position 23

-78. (canceled)
